The potential for psychedelic drugs to treat Long COVID, a chronic condition with no proven cure, is gaining attention.
me
The potential for psychedelic drugs to treat Long COVID, a chronic condition with no proven cure, is
gaining attention
.
While much psychedelic research has focused on mental health conditions, there is growing interest in exploring their potential benefits for Long COVID, Time reports.
Some patients have reported significant improvements in symptoms such as fatigue, cognitive function, and memory after using psychedelics, prompting researchers to study their therapeutic
potential.
However, psychedelic drugs are currently federally illegal and categorized as substances with a high potential for abuse and no accepted medical use, creating significant research
barriers.
Despite this, some researchers are pushing for funding to explore the therapeutic potential of psilocybin, the psychoactive component of magic mushrooms, for Long COVID and other
conditions.
Some rodent studies have suggested that psychedelics have anti-inflammatory effects, which could be relevant to treating Long COVID.
Clinical trials are ongoing to explore the potential of psychedelic treatments for Long COVID.
